News

Arizona’s MedPlast acquires San Antonio biotech company

MedPlast Inc. will get a 135,000-square-foot facility as part of its purchase of San Antonio's Coastal ...

Meet the new CEO tasked with taking SA drug developer's first human product to market

Rapamycin Holdings, Inc. has tapped Dan Hargrove as its new CEO. SABJ FILE PHOTO W. Scott Bailey Reporter/Project ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
Arizona’s MedPlast acquires San Antonio biotech company
July 13, 2017

MedPlast Inc. will get a 135,000-square-foot facility as part of its purchase of San Antonio's Coastal Life Technologies.

W. Scott Bailey
Reporter/Project Coordinator
San Antonio Business Journal

Another San Antonio biotech company has been sold to an out-of-state buyer. The latest transaction involves Coastal Life Technologies, which has been acquired by Tempe, Arizona-based MedPlast Inc.

While terms of the deal were not disclosed, the parties involved said that Coastal Life Technologies will remain in San Antonio and retain its president, David Huff, who will now report to Bill Flaherty, president of Medical Device Solutions for MedPlast.

The Arizona company provides a variety of services to medical device companies across the world. What it gets in Coastal is a nearly 30-year-old business specializing in the design, engineering, assembling, manufacturing and packaging of single-use surgical devices for medical device manufacturers

MedPlast also gets access to Coastal’s new 135,000 square-foot facility in San Antonio.

Huff said the sale to MedPlast represents a great opportunity for Coastal to align with a complementary business through a deal that makes both companies more competitive.

Flaherty said in a statement that Coastal Life “has strong operational device assembly competencies that will enrich our overall quality and productivity, and bring us another step closer to becoming the first end-to-end contract manufacturing services provider in the medical device industry."

On June 5, I reported that a separate San Antonio biotech company, NuPak Medical Ltd., has been acquired. New Jersey-based Katena Products is the new owner of the Alamo City business.

“We started the discussions in late January,” said Cocke, who will serve as vice president of manufacturing for Katena’s San Antonio operations.”Katena has been in an acquisition mode. It made sense to integrate.”

That deal is expected to provide NuPak Medical greater stability.

Stay informed. Subscribe to BioMed SA news alerts.